News
Allogene Therapeutics continues to advance its pipeline, with notable progress in key clinical trials and upcoming data ...
Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada
Medulloblastoma (MB) is the most common malignant brain tumour in children and is classified into four subgroups, with Group ...
For Glacier High School senior Abby Dose, the upcoming weekend of graduation celebrations doesn't just signify the end of her high school career. It also marks the one-year anniversary of the day her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results